These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 25292190)

  • 1. miR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1.
    Xu M; Jin H; Xu CX; Sun B; Song ZG; Bi WZ; Wang Y
    Mol Ther; 2015 Jan; 23(1):89-98. PubMed ID: 25292190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA‑487b‑3p inhibits osteosarcoma chemoresistance and metastasis by targeting ALDH1A3.
    Cheng M; Duan PG; Gao ZZ; Dai M
    Oncol Rep; 2020 Dec; 44(6):2691-2700. PubMed ID: 33125503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the Notch signaling pathway attenuates progression of cell motility, metastasis, and epithelial-to-mesenchymal transition-like phenomena induced by low concentrations of cisplatin in osteosarcoma.
    Dai G; Liu G; Zheng D; Song Q
    Eur J Pharmacol; 2021 May; 899():174058. PubMed ID: 33757752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
    Zhang Y; Wang F; Wang L; Zhang Q
    World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1.
    Lin BC; Huang D; Yu CQ; Mou Y; Liu YH; Zhang DW; Shi FJ
    Med Sci Monit; 2016 May; 22():1761-5. PubMed ID: 27222034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma.
    Sun X; Tian C; Zhang H; Han K; Zhou M; Gan Z; Zhu H; Min D
    Biomed Pharmacother; 2020 Aug; 128():110201. PubMed ID: 32460190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-106a-5p Suppresses the Proliferation, Migration, and Invasion of Osteosarcoma Cells by Targeting HMGA2.
    He QY; Wang GC; Zhang H; Tong DK; Ding C; Liu K; Ji F; Zhu X; Yang S
    DNA Cell Biol; 2016 Sep; 35(9):506-20. PubMed ID: 27383537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting αB-crystallin.
    Wang SN; Luo S; Liu C; Piao Z; Gou W; Wang Y; Guan W; Li Q; Zou H; Yang ZZ; Wang D; Wang Y; Xu M; Jin H; Xu CX
    Mol Ther; 2017 Sep; 25(9):2140-2149. PubMed ID: 28648665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. THE INFLUENCE AND REGULATORY MECHANISM OF Y-BOX BINDING PROTEIN 1 IN OSTEOSARCOMA AND ITS SIGNIFICANCE.
    Zhou WP; Liu X; Yang Y; Liu YF
    J Biol Regul Homeost Agents; 2015; 29(2):485-91. PubMed ID: 26122241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-204 inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in osteosarcoma cells via targeting Sirtuin 1.
    Shi Y; Huang J; Zhou J; Liu Y; Fu X; Li Y; Yin G; Wen J
    Oncol Rep; 2015 Jul; 34(1):399-406. PubMed ID: 25998694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KDM6B-mediated histone demethylation of LDHA promotes lung metastasis of osteosarcoma.
    Jiang Y; Li F; Gao B; Ma M; Chen M; Wu Y; Zhang W; Sun Y; Liu S; Shen H
    Theranostics; 2021; 11(8):3868-3881. PubMed ID: 33664867
    [No Abstract]   [Full Text] [Related]  

  • 12. Upregulation of miR-328 and inhibition of CREB-DNA-binding activity are critical for resveratrol-mediated suppression of matrix metalloproteinase-2 and subsequent metastatic ability in human osteosarcomas.
    Yang SF; Lee WJ; Tan P; Tang CH; Hsiao M; Hsieh FK; Chien MH
    Oncotarget; 2015 Feb; 6(5):2736-53. PubMed ID: 25605016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Noncoding RNA SNHG7 Promotes the Tumor Growth and Epithelial-to-Mesenchymal Transition via Regulation of miR-34a Signals in Osteosarcoma.
    Deng Y; Zhao F; Zhang Z; Sun F; Wang M
    Cancer Biother Radiopharm; 2018 Nov; 33(9):365-372. PubMed ID: 29989838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22.
    Zhu K; Yuan Y; Wen J; Chen D; Zhu W; Ouyang Z; Wang W
    Aging (Albany NY); 2020 Apr; 12(8):6644-6666. PubMed ID: 32302291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical case report of patients with osteosarcoma and anticancer benefit of calycosin against human osteosarcoma cells.
    Qiu R; Ma G; Li X; Shi Q; Li X; Zhou X; Tang Y; Xie Z; Liao S; Qin Y; Wang R; Ye Y; Luo J; Zhang J
    J Cell Biochem; 2019 Jun; 120(6):10697-10706. PubMed ID: 30652346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-210-5p promotes epithelial-mesenchymal transition by inhibiting PIK3R5 thereby activating oncogenic autophagy in osteosarcoma cells.
    Liu W; Jiang D; Gong F; Huang Y; Luo Y; Rong Y; Wang J; Ge X; Ji C; Fan J; Cai W
    Cell Death Dis; 2020 Feb; 11(2):93. PubMed ID: 32024814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA nuclear-enriched abundant transcript 1 promotes cell proliferation and invasion by targeting miR-186-5p/HIF-1α in osteosarcoma.
    Tan H; Zhao L
    J Cell Biochem; 2019 Apr; 120(4):6502-6514. PubMed ID: 30485482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA‑CASC15 promotes osteosarcoma proliferation and metastasis by regulating epithelial‑mesenchymal transition via the Wnt/β‑catenin signaling pathway.
    Wang H; Zhang P
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-532-5p is a prognostic marker and inhibits the aggressive phenotypes of osteosarcoma through targeting CXCL2.
    Ma Y; Zhao HX; Shi YJ; Cheng MG
    Kaohsiung J Med Sci; 2020 Nov; 36(11):885-894. PubMed ID: 32643867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
    Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
    Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.